Key imidazolyl groups induce phenylalanine flipping, significantly enhancing the cellular potency of BRD9 inhibitors for treating acute myeloid leukemia (AML). The compounds demonstrated potent binding affinity and anti-tumor efficacy in the MV4-11 xenograft mouse model.
This issue features revolutionary research in drug design, artificial intelligence for radiopharmaceuticals, hiPSC-derived liver organoids, and precision malignancy therapy. Groundbreaking studies showcase the potential of graph neural networks, AI-driven advancements, and innovative treatments.
Researchers developed probiotic living microneedles that penetrate biofilms, reducing pathogenic burden via photothermal killing and NIR-promoted antibiotic release. In vitro and in vivo studies show >99.9% bactericidal efficiency and 93.9% wound closure rates.
eQTLs modulate gene expression through various molecular mechanisms, providing insights into disease etiology. eQTL analysis has elucidated the functional relationship between genetic variants and complex traits in diseases such as RA, T2D, breast cancer, and SZ.
A novel 18F-labeled reversible-binding radioligand, [18F]MAGL-2011, was developed for imaging monoacylglycerol lipase with positron emission tomography. The compound demonstrated favorable brain uptake and excellent in vivo binding specificity.
Researchers discovered peptidomimetic inhibitors that target the hydrophobic grooves on the surface of the CBP KIX domain, disrupting CREB/CBP interactions. These stapled sulfonyl-γ-AAp peptide derivatives exhibit effective antiproliferative activity in cell-based assays and inhibit tumor growth in vivo.
Researchers have developed a new approach to targeting hematological malignancies using degradation tail-driven CELMoD–antibody conjugates. These conjugates, such as Dara-VA-I034, demonstrate potent antiproliferative effects and complete tumor eradication at low doses.
Researchers developed exosomes targeting myofibroblasts loaded with siFKBP10, which silenced FKBP10 gene expression, inhibiting fibroblast activation and extracellular matrix deposition. This study demonstrates a promising therapeutic strategy for idiopathic pulmonary fibrosis (IPF) treatment.
Researchers developed an injectable hydrogel delivery system to co-deliver oncolytic adenovirus and melphalan for treating retinoblastoma. The treatment effectively controlled tumor growth, prevented brain metastasis, and preserved retinal structure and function.
The FXYD family proteins have diverse physiological and pathological roles, influencing ion transport in different organs and tissues. Altered expression or dysfunction of these proteins is associated with numerous diseases, including cardiovascular, neurological, renal, and cancer disorders.
A recent study found that Dlc1 deletion affects cardiac differentiation in mouse embryonic stem cells by activating the canonical Wnt pathway. The study showed that Dlc1 deficiency promotes mesoderm lineage specification, leading to the accumulation of cardiac progenitors and blocking their further differentiation into cardiomyocytes.
A recent study reveals how the C/G fusion hijacks DNA methylation and chromatin architecture to drive aggressive acute myeloid leukemia in children. The study identifies DNMT3B as a critical effector of the fusion, highlighting its potential as a therapeutic target.
Researchers discovered that SUMO E1 enzyme activity drives lens fibrosis, while its inhibition with ML792 disrupts SMAD4 SUMOylation and subsequent TGFβ2-induced fibrotic transformation. This study establishes a novel SUMOylation-SMAD4 regulatory axis in ocular fibrosis.
Neoliensinine, a tribenzylisoquinoline alkaloid, has potent anti-T-CM activity and induces TUBA1B-mediated STING degradation via the lysosomal pathway. This promotes lysosome-dependent cell death in T-CM cells.
TBX4 plays a central role in regulating mesenchymal-epithelial communication during organogenesis. It also has significant implications in respiratory medicine, orthopedics, and oncology.
A new study identifies miR-101a as a critical suppressor of chondrocyte hypertrophy, reducing Cox-2 expression and attenuating structural damage in an OA mouse model. This highlights miR-101a's potential as a therapeutic candidate for osteoarthritis intervention.
The partnership expands global reach, discoverability, and researcher engagement for four Compuscript biomedical journals. Researchers can now easily discover journal content through a dedicated Journal Home presence on ResearchGate.
The review highlights the progress in gene-editing nucleases and delivery vectors for in vivo gene therapy, enabling targeted correction of genetic errors. Key examples include FDA-approved products targeting monogenic disorders and cancers, showcasing the therapeutic promise of combining genome editors with advanced delivery platforms.
Research highlights the role of ATAD2 in promoting glioma progression by co-activating PDK1 with E2F1, leading to poorer prognoses in patients. A personalized prognostic nomogram using CTARS has been developed for predicting clinical outcomes.
Researchers have discovered that ATAD2 promotes glioma progression by working with E2F1 to activate PDK1. The study also found that high levels of ATAD2 are associated with poorer outcomes in glioma patients.
The review highlights the complex relationship between mitochondria and tumorigenesis, exploring molecular mechanisms underlying this association. Mitochondrial dysfunction is linked to various cancers, and targeting mitochondria represents an ideal anti-tumor therapeutic approach.
Research highlights CNDP enzymes as key regulators of metabolic disorders and oncogenic pathways. Genetic polymorphisms and molecular mechanisms revealed, linking CNDP function to energy balance and obesity management. Future studies focus on developing targeted therapies and diagnostic tools.
The International Open Medical Journal (IOMJ) has been launched by Asia-Pacific experts, aiming to promote high academic independence and benchmarking against top international publications. The journal will focus on core areas such as global consensus guidelines, multi-omics, AI-driven diagnostics and treatment, and clinical translation.
Colorectal cancer research is transformed by patient-derived xenograft models, which faithfully replicate human tumors in immunodeficient mice. These models preserve the tumor microenvironment and clonal diversity, enabling drug discovery and biomarker identification, and driving personalized treatment approaches.
Researchers highlight m6A RNA modification's role in regulating gene expression and cellular processes in CVDs. Dysregulation of m6A has been linked to vascular inflammation, endothelial dysfunction, and cardiac remodeling.
Bryophytes, including mosses, liverworts, and hornworts, have been found to be a significant source of trace evidence in forensic science. The new study provides a comprehensive review of their role in forensic botany, highlighting their potential for linking suspects, victims, and locations.
PRMT5 promotes proliferation, metastasis, therapy resistance, and an immunosuppressive tumor microenvironment in various solid malignancies. Targeting PRMT5 with inhibitors has shown promising therapeutic effects in several cancers.
Researchers found that vitamin D receptor deficiency disrupts autophagy and promotes epithelial-mesenchymal transition, leading to endometrial fibrosis. Vitamin D or VDR-targeted therapy may serve as a promising approach for preventing or treating intrauterine adhesion.
Biomechanical forces play a crucial role in regulating cancer invasion and metastasis by modulating cell membrane topology, actin cytoskeletal remodeling, and mechanical stress adaptation. The review highlights the importance of three-dimensional tumor models and novel therapies targeting mechanical signaling pathways to inhibit invasion.
Research highlights the importance of mitochondria-endoplasmic reticulum cross-talk in colorectal cancer, regulating Ca2+ homeostasis and lipid metabolism. Novel therapeutic strategies targeting this crosstalk may suppress CRC progression and improve patient outcomes.
The Forensic Sciences Research journal has been included in the Stanford University database, recognizing its esteemed editorial board members for their significant impact on forensic science. The inclusion demonstrates the journal's commitment to advancing excellence in the field and supporting researchers worldwide.
Researchers introduce theoretical foundations of HMMs, including evaluation, decoding, and learning algorithms, for applications in bioinformatics such as transmembrane protein prediction and gene finding. HMMs are expected to remain central to advancing genome annotation and functional genomics.
The review reveals m⁶A's dynamic role in regulating female reproductive physiology, including oocyte maturation, granulosa cell function, and endometrial receptivity. Dysregulation of m⁶A is linked to pathologies such as endometriosis, PCOS, and recurrent miscarriage.
The intra-tumoral microbiome influences cancer initiation, progression, and immune regulation through various mechanisms. Targeting the tumor microbiota holds promise for precision medicine and cancer therapy.
The review highlights perilipin 2's role in regulating hepatic lipid metabolism and its implications in various liver diseases, including hepatitis B, C, and alcoholic liver disease. PLIN2 acts as a biomarker for diagnosis and prognosis, while also influencing treatment response and tumor susceptibility.
Researchers found high SIGLEC15 expression correlates with improved survival in breast cancer patients. SIGLEC15 suppresses EMT progression and metastatic potential by down-regulating ZEB1, N-cadherin, and vimentin levels. It also shows vulnerability to the MDM2 inhibitor Nutlin-3a, suggesting a potential therapeutic strategy.
Recent studies suggest that cell cycle proteins, including cyclins and CDKs, play a regulatory role in the tumor microenvironment. Inhibiting these proteins has shown promise in converting immunologically 'cold' tumors into 'hot' tumors and suppressing tumor progression.
Epithelial-mesenchymal transition (EMT) is a key driver of glioblastoma progression and therapy resistance. Emerging strategies to disrupt EMT signaling, such as natural compounds and small-molecule inhibitors, hold promise for reducing tumor invasion and enhancing sensitivity to standard therapies.
A recent study revealed ROS-induced oxidative stress accelerates hypertrophic cardiomyopathy (HCM) in MYBPC3-deleted hiPSC-CMs. The researchers found that melatonin alleviates HCM by inhibiting the PI3K/AKT/FOXO3a signaling pathways.
Researchers found miR-378 suppresses bone marrow stromal cell osteogenesis and hinders fracture healing in an OVX-induced osteoporosis model. MiR-378 overexpression increased osteoclastogenesis by activating NF-κB signaling pathways, impairing bone formation.
Researchers identified NBL1 as a key driver of ovarian cancer metastasis through its activation of the Jak/Stat3 pathway. NBL1 expression levels strongly correlated with advanced clinical stage and poor survival outcomes.
A study found that BMP9 signaling is crucial for tooth root development, influencing odontoblast differentiation and HERS cell proliferation. The findings reveal a complex regulatory network involving TGF-β and Wnt signaling pathways.
A recent study found that RAB26 is mainly expressed in luminal and basal/intermediate prostate cancer cells, correlating with advanced pathological stage and poor patient prognosis. RAB26 promotes proliferation, migration, and invasion of PCa cells while inhibiting apoptosis.
A recent study reveals that circFKBP8(5S,6) or cFKBP8 promote susceptibility to chronic unpredictable mild stress in mice by down-regulating DRD3 expression and disrupting AMPK/mTOR/ULK1 autophagy signaling. Behavioral studies demonstrate exacerbated depressive-like phenotypes, which can be mitigated by the DRD3 agonist cariprazine.
A recent study identifies C1orf122 as a novel biomarker for hepatocellular carcinoma (HCC) progression and prognosis. C1orf122 promotes HCC via the SRPK1-PI3K/AKT/GSK3β axis, enhancing cell proliferation, suppressing apoptosis, and facilitating cell migration.
Researchers investigated tirzepatide's therapeutic efficacy on MASLD, a complex liver disease characterized by abnormal lipid accumulation and inflammation. Tirzepatide alleviated hepatic steatosis in mouse models by enhancing lipolysis and reducing lipid uptake through the regulation of CD36 and OBP2A.
The article explores the fundamental principles and applications of current oral anti-tumor and anti-infective vaccines, discussing considerations necessary for designing future oral vaccines. Oral vaccines can be used for tumor therapy and prevention of various infectious diseases, improving immune defense.
Researchers explore FtsZ's potential as a therapeutic target for bacterial cell division, highlighting current advances and future directions. Despite progress, challenges persist, including weak binding affinities and evolving drug resistance.
Resistance mutations and the blood-brain barrier pose significant hurdles to targeted treatment efficacy in NSCLC patients with brain metastases. Emerging evidence suggests that ABCB1 and ABCG2 drug transporters play a crucial role in differential efflux of targeted inhibitors at the BBB.
This study identifies a high-efficient platform for discovering key anti-Notum constituents from herbal medicines, with 5-Methoxypsoralen emerging as a promising anti-GIOP agent. The compound promotes osteoblast differentiation and activates Wnt signaling in dexamethasone-challenged osteoblasts.